eligibility for glp 1 BMI & the Role of Semaglutide GLP-1 in Weight Loss Medical Weight Loss GLP-1/GIP |

Elevated fatty acids (FAs) activate Toll-like receptors (TLRs) in macrophages, which act in synergy with MSU crystals to trigger NLRP3 inflammasome activation and pro-inflammatory cytokine release (e.g., IL-1), thereby initiating the inflammatory cascade

A selective CPT-1 stimulator produced long lasting hypophagia (reduced food intake) and persistent weight loss [75]

Semaglutide (marketed as Wegovy for weight management and Ozempic for diabetes) produced an average 15.8% body weight reduction over 68 weeks in the STEP trials

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

20 years later, they are now being marketed specifically for weight loss